1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Intravenous 1.2.3 Oral 1.3 Market by Application 1.3.1 Global Drug Repurposing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cardiovascular Disorders 1.3.3 Central Nervous Disorders 1.3.4 Oncology 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Drug Repurposing Market Perspective (2016-2027) 2.2 Drug Repurposing Growth Trends by Regions 2.2.1 Drug Repurposing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Drug Repurposing Historic Market Share by Regions (2016-2021) 2.2.3 Drug Repurposing Forecasted Market Size by Regions (2022-2027) 2.3 Drug Repurposing Industry Dynamic 2.3.1 Drug Repurposing Market Trends 2.3.2 Drug Repurposing Market Drivers 2.3.3 Drug Repurposing Market Challenges 2.3.4 Drug Repurposing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Drug Repurposing Players by Revenue 3.1.1 Global Top Drug Repurposing Players by Revenue (2016-2021) 3.1.2 Global Drug Repurposing Revenue Market Share by Players (2016-2021) 3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Drug Repurposing Revenue 3.4 Global Drug Repurposing Market Concentration Ratio 3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2020 3.5 Drug Repurposing Key Players Head office and Area Served 3.6 Key Players Drug Repurposing Product Solution and Service 3.7 Date of Enter into Drug Repurposing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Drug Repurposing Breakdown Data by Type 4.1 Global Drug Repurposing Historic Market Size by Type (2016-2021) 4.2 Global Drug Repurposing Forecasted Market Size by Type (2022-2027) 5 Drug Repurposing Breakdown Data by Application 5.1 Global Drug Repurposing Historic Market Size by Application (2016-2021) 5.2 Global Drug Repurposing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Drug Repurposing Market Size (2016-2027) 6.2 North America Drug Repurposing Market Size by Type 6.2.1 North America Drug Repurposing Market Size by Type (2016-2021) 6.2.2 North America Drug Repurposing Market Size by Type (2022-2027) 6.2.3 North America Drug Repurposing Market Size by Type (2016-2027) 6.3 North America Drug Repurposing Market Size by Application 6.3.1 North America Drug Repurposing Market Size by Application (2016-2021) 6.3.2 North America Drug Repurposing Market Size by Application (2022-2027) 6.3.3 North America Drug Repurposing Market Size by Application (2016-2027) 6.4 North America Drug Repurposing Market Size by Country 6.4.1 North America Drug Repurposing Market Size by Country (2016-2021) 6.4.2 North America Drug Repurposing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Drug Repurposing Market Size (2016-2027) 7.2 Europe Drug Repurposing Market Size by Type 7.2.1 Europe Drug Repurposing Market Size by Type (2016-2021) 7.2.2 Europe Drug Repurposing Market Size by Type (2022-2027) 7.2.3 Europe Drug Repurposing Market Size by Type (2016-2027) 7.3 Europe Drug Repurposing Market Size by Application 7.3.1 Europe Drug Repurposing Market Size by Application (2016-2021) 7.3.2 Europe Drug Repurposing Market Size by Application (2022-2027) 7.3.3 Europe Drug Repurposing Market Size by Application (2016-2027) 7.4 Europe Drug Repurposing Market Size by Country 7.4.1 Europe Drug Repurposing Market Size by Country (2016-2021) 7.4.2 Europe Drug Repurposing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Drug Repurposing Market Size (2016-2027) 8.2 Asia-Pacific Drug Repurposing Market Size by Type 8.2.1 Asia-Pacific Drug Repurposing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Drug Repurposing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Drug Repurposing Market Size by Type (2016-2027) 8.3 Asia-Pacific Drug Repurposing Market Size by Application 8.3.1 Asia-Pacific Drug Repurposing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Drug Repurposing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Drug Repurposing Market Size by Application (2016-2027) 8.4 Asia-Pacific Drug Repurposing Market Size by Region 8.4.1 Asia-Pacific Drug Repurposing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Drug Repurposing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Drug Repurposing Market Size (2016-2027) 9.2 Latin America Drug Repurposing Market Size by Type 9.2.1 Latin America Drug Repurposing Market Size by Type (2016-2021) 9.2.2 Latin America Drug Repurposing Market Size by Type (2022-2027) 9.2.3 Latin America Drug Repurposing Market Size by Type (2016-2027) 9.3 Latin America Drug Repurposing Market Size by Application 9.3.1 Latin America Drug Repurposing Market Size by Application (2016-2021) 9.3.2 Latin America Drug Repurposing Market Size by Application (2022-2027) 9.3.3 Latin America Drug Repurposing Market Size by Application (2016-2027) 9.4 Latin America Drug Repurposing Market Size by Country 9.4.1 Latin America Drug Repurposing Market Size by Country (2016-2021) 9.4.2 Latin America Drug Repurposing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Drug Repurposing Market Size (2016-2027) 10.2 Middle East & Africa Drug Repurposing Market Size by Type 10.2.1 Middle East & Africa Drug Repurposing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Drug Repurposing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Drug Repurposing Market Size by Type (2016-2027) 10.3 Middle East & Africa Drug Repurposing Market Size by Application 10.3.1 Middle East & Africa Drug Repurposing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Drug Repurposing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Drug Repurposing Market Size by Application (2016-2027) 10.4 Middle East & Africa Drug Repurposing Market Size by Country 10.4.1 Middle East & Africa Drug Repurposing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Drug Repurposing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Drug Repurposing Introduction 11.1.4 Pfizer Revenue in Drug Repurposing Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Drug Repurposing Introduction 11.2.4 Roche Revenue in Drug Repurposing Business (2016-2021) 11.2.5 Roche Recent Development 11.3 Novartis AG 11.3.1 Novartis AG Company Details 11.3.2 Novartis AG Business Overview 11.3.3 Novartis AG Drug Repurposing Introduction 11.3.4 Novartis AG Revenue in Drug Repurposing Business (2016-2021) 11.3.5 Novartis AG Recent Development 11.4 Abbott Healthcare 11.4.1 Abbott Healthcare Company Details 11.4.2 Abbott Healthcare Business Overview 11.4.3 Abbott Healthcare Drug Repurposing Introduction 11.4.4 Abbott Healthcare Revenue in Drug Repurposing Business (2016-2021) 11.4.5 Abbott Healthcare Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Drug Repurposing Introduction 11.5.4 Johnson & Johnson Revenue in Drug Repurposing Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Sandoz 11.6.1 Sandoz Company Details 11.6.2 Sandoz Business Overview 11.6.3 Sandoz Drug Repurposing Introduction 11.6.4 Sandoz Revenue in Drug Repurposing Business (2016-2021) 11.6.5 Sandoz Recent Development 11.7 Mylan Inc. 11.7.1 Mylan Inc. Company Details 11.7.2 Mylan Inc. Business Overview 11.7.3 Mylan Inc. Drug Repurposing Introduction 11.7.4 Mylan Inc. Revenue in Drug Repurposing Business (2016-2021) 11.7.5 Mylan Inc. Recent Development 11.8 Teva Pharmaceuticals 11.8.1 Teva Pharmaceuticals Company Details 11.8.2 Teva Pharmaceuticals Business Overview 11.8.3 Teva Pharmaceuticals Drug Repurposing Introduction 11.8.4 Teva Pharmaceuticals Revenue in Drug Repurposing Business (2016-2021) 11.8.5 Teva Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Drug Repurposing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Intravenous Table 3. Key Players of Oral Table 4. Global Drug Repurposing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Drug Repurposing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Drug Repurposing Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Drug Repurposing Market Share by Regions (2016-2021) Table 8. Global Drug Repurposing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Drug Repurposing Market Share by Regions (2022-2027) Table 10. Drug Repurposing Market Trends Table 11. Drug Repurposing Market Drivers Table 12. Drug Repurposing Market Challenges Table 13. Drug Repurposing Market Restraints Table 14. Global Drug Repurposing Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Drug Repurposing Market Share by Players (2016-2021) Table 16. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repurposing as of 2020) Table 17. Ranking of Global Top Drug Repurposing Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Drug Repurposing Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Drug Repurposing Product Solution and Service Table 21. Date of Enter into Drug Repurposing Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Drug Repurposing Market Size by Type (2016-2021) (US$ Million) Table 24. Global Drug Repurposing Revenue Market Share by Type (2016-2021) Table 25. Global Drug Repurposing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Drug Repurposing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Drug Repurposing Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Drug Repurposing Revenue Market Share by Application (2016-2021) Table 29. Global Drug Repurposing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Drug Repurposing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Drug Repurposing Market Size by Type (2016-2021) (US$ Million) Table 32. North America Drug Repurposing Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Drug Repurposing Market Size by Application (2016-2021) (US$ Million) Table 34. North America Drug Repurposing Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Drug Repurposing Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Drug Repurposing Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Drug Repurposing Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Drug Repurposing Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Drug Repurposing Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Drug Repurposing Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Drug Repurposing Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Drug Repurposing Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Drug Repurposing Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Drug Repurposing Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Drug Repurposing Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Drug Repurposing Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Drug Repurposing Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Drug Repurposing Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Drug Repurposing Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Drug Repurposing Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Drug Repurposing Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Drug Repurposing Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Drug Repurposing Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Drug Repurposing Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Drug Repurposing Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Drug Repurposing Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Drug Repurposing Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Drug Repurposing Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Drug Repurposing Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Drug Repurposing Market Size by Country (2022-2027) & (US$ Million) Table 61. Pfizer Company Details Table 62. Pfizer Business Overview Table 63. Pfizer Drug Repurposing Product Table 64. Pfizer Revenue in Drug Repurposing Business (2016-2021) & (US$ Million) Table 65. Pfizer Recent Development Table 66. Roche Company Details Table 67. Roche Business Overview Table 68. Roche Drug Repurposing Product Table 69. Roche Revenue in Drug Repurposing Business (2016-2021) & (US$ Million) Table 70. Roche Recent Development Table 71. Novartis AG Company Details Table 72. Novartis AG Business Overview Table 73. Novartis AG Drug Repurposing Product Table 74. Novartis AG Revenue in Drug Repurposing Business (2016-2021) & (US$ Million) Table 75. Novartis AG Recent Development Table 76. Abbott Healthcare Company Details Table 77. Abbott Healthcare Business Overview Table 78. Abbott Healthcare Drug Repurposing Product Table 79. Abbott Healthcare Revenue in Drug Repurposing Business (2016-2021) & (US$ Million) Table 80. Abbott Healthcare Recent Development Table 81. Johnson & Johnson Company Details Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Drug Repurposing Product Table 84. Johnson & Johnson Revenue in Drug Repurposing Business (2016-2021) & (US$ Million) Table 85. Johnson & Johnson Recent Development Table 86. Sandoz Company Details Table 87. Sandoz Business Overview Table 88. Sandoz Drug Repurposing Product Table 89. Sandoz Revenue in Drug Repurposing Business (2016-2021) & (US$ Million) Table 90. Sandoz Recent Development Table 91. Mylan Inc. Company Details Table 92. Mylan Inc. Business Overview Table 93. Mylan Inc. Drug Repurposing Product Table 94. Mylan Inc. Revenue in Drug Repurposing Business (2016-2021) & (US$ Million) Table 95. Mylan Inc. Recent Development Table 96. Teva Pharmaceuticals Company Details Table 97. Teva Pharmaceuticals Business Overview Table 98. Teva Pharmaceuticals Revenue in Drug Repurposing Business (2016-2021) & (US$ Million) Table 99. Teva Pharmaceuticals Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Drug Repurposing Market Share by Type: 2020 VS 2027 Figure 2. Intravenous Features Figure 3. Oral Features Figure 4. Global Drug Repurposing Market Share by Application: 2020 VS 2027 Figure 5. Cardiovascular Disorders Case Studies Figure 6. Central Nervous Disorders Case Studies Figure 7. Oncology Case Studies Figure 8. Others Case Studies Figure 9. Drug Repurposing Report Years Considered Figure 10. Global Drug Repurposing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Drug Repurposing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Drug Repurposing Market Share by Regions: 2020 VS 2027 Figure 13. Global Drug Repurposing Market Share by Regions (2022-2027) Figure 14. Global Drug Repurposing Market Share by Players in 2020 Figure 15. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repurposing as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Drug Repurposing Revenue in 2020 Figure 17. Global Drug Repurposing Revenue Market Share by Type (2016-2021) Figure 18. Global Drug Repurposing Revenue Market Share by Type (2022-2027) Figure 19. North America Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Drug Repurposing Market Share by Type (2016-2027) Figure 21. North America Drug Repurposing Market Share by Application (2016-2027) Figure 22. North America Drug Repurposing Market Share by Country (2016-2027) Figure 23. United States Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Drug Repurposing Market Share by Type (2016-2027) Figure 27. Europe Drug Repurposing Market Share by Application (2016-2027) Figure 28. Europe Drug Repurposing Market Share by Country (2016-2027) Figure 29. Germany Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Drug Repurposing Market Share by Type (2016-2027) Figure 37. Asia-Pacific Drug Repurposing Market Share by Application (2016-2027) Figure 38. Asia-Pacific Drug Repurposing Market Share by Region (2016-2027) Figure 39. China Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Drug Repurposing Market Share by Type (2016-2027) Figure 47. Latin America Drug Repurposing Market Share by Application (2016-2027) Figure 48. Latin America Drug Repurposing Market Share by Country (2016-2027) Figure 49. Mexico Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Drug Repurposing Market Share by Type (2016-2027) Figure 53. Middle East & Africa Drug Repurposing Market Share by Application (2016-2027) Figure 54. Middle East & Africa Drug Repurposing Market Share by Country (2016-2027) Figure 55. Turkey Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Pfizer Revenue Growth Rate in Drug Repurposing Business (2016-2021) Figure 59. Roche Revenue Growth Rate in Drug Repurposing Business (2016-2021) Figure 60. Novartis AG Revenue Growth Rate in Drug Repurposing Business (2016-2021) Figure 61. Abbott Healthcare Revenue Growth Rate in Drug Repurposing Business (2016-2021) Figure 62. Johnson & Johnson Revenue Growth Rate in Drug Repurposing Business (2016-2021) Figure 63. Sandoz Revenue Growth Rate in Drug Repurposing Business (2016-2021) Figure 64. Mylan Inc. Revenue Growth Rate in Drug Repurposing Business (2016-2021) Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Drug Repurposing Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Pfizer Roche Novartis AG Abbott Healthcare Johnson & Johnson Sandoz Mylan Inc. Teva Pharmaceuticals